Key result
Postprocedural cTnI elevation in high-risk NSTE-ACS patients undergoing PCI is associated with abnormal tissue-level perfusion (TMPG 0/1 in 43% vs 7%; P<0.02).
Why the study?
Is postprocedural cTnI elevation associated with abnormal tissue-level perfusion in high-risk patients with NSTE-ACS undergoing PCI?
Population
42 high-risk patients with non-ST-segment-elevation acute coronary syndromes presenting with angina at rest…
Comparison
Percutaneous coronary intervention performed… vs Patients without postprocedural cTnI elevation
Design
Cohort
Follow-up
Immediately after PCI
Authors
Loading...
May reflect microvascular dysfunction after PCI; hypothesis-generating for targeted perfusion strategies in NSTE-ACS.
Observational (n=42)
Is postprocedural cTnI elevation associated with abnormal tissue-level perfusion in high-risk patients with NSTE-ACS undergoing PCI?
Absolute Event Rate: 43% vs 7%
p-value: p=<0.02
Postprocedural troponin I elevation after PCI in high-risk NSTE-ACS patients is associated with abnormal tissue-level perfusion, suggesting microvascular dysfunction as a pathophysiological mechanism.
Bolognese et al. (2004) conducted an observational in High-risk non-ST-segment-elevation acute coronary syndromes (NSTE-ACS) (n=42). Postprocedural cTnI elevation vs. No postprocedural cTnI elevation was evaluated on TIMI myocardial perfusion grade (TMPG) 0/1 after PCI (p=<0.02). Postprocedural cTnI elevation in high-risk NSTE-ACS patients undergoing PCI is associated with abnormal tissue-level perfusion (TMPG 0/1 in 43% vs 7%; P<0.02).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: